SSMJX
Price
$372.19
Change
+$1.57 (+0.42%)
Updated
Sep 22 closing price
Net Assets
846.53M
VIEIX
Price
$181.10
Change
+$0.89 (+0.49%)
Updated
Sep 22 closing price
Net Assets
95.33B
Interact to see
Advertisement

SSMJX vs VIEIX

SSMJX vs VIEIX Comparison Chart in %
View a ticker or compare two or three
VS
SSMJX vs. VIEIX commentary
Sep 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SSMJX is a Hold and VIEIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIEIX has more cash in the bank: 95.3B vs. SSMJX (847M). SSMJX pays higher dividends than VIEIX: SSMJX (1.28) vs VIEIX (1.01). SSMJX was incepted earlier than VIEIX: SSMJX (11 years) vs VIEIX (29 years). SSMJX (0.58) is less costly to investors than VIEIX (0.04). SSMJX is a more actively managed with annual turnover of: 26.00 vs. VIEIX (12.00). SSMJX has a lower initial minimum investment than VIEIX: SSMJX (2000) vs VIEIX (5000000). VIEIX annual gain was more profitable for investors over the last year : 11.20 vs. SSMJX (8.86). VIEIX return over 5 years is better than : 27.84 vs. SSMJX (6.75).
SSMJXVIEIXSSMJX / VIEIX
Total Expense Ratio0.490.041,238%
Annual Report Gross Expense Ratio0.580.041,455%
Fund Existence11 years29 years-
Gain YTD13.06312.703103%
Front Load5%N/A-
Min. Initial Investment200050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets847M95.3B1%
Annual Yield % from dividends1.281.01126%
Returns for 1 year8.8611.2079%
Returns for 3 years64.8966.5298%
Returns for 5 years6.7527.8424%
Returns for 10 years107.34166.9964%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JDBAX49.930.41
+0.83%
Janus Henderson Balanced A
JVTSX85.420.35
+0.41%
Janus Henderson Venture S
GRHAX22.11N/A
N/A
Goehring & Rozencwajg Resources Retail
BHCHX22.95N/A
N/A
Baron Health Care Instl
MAIMX27.11N/A
N/A
Victory Integrity Mid-Cap Value A